Joe Pardo

459 total citations
7 papers, 336 citations indexed

About

Joe Pardo is a scholar working on Infectious Diseases, Clinical Biochemistry and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Joe Pardo has authored 7 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Clinical Biochemistry and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Joe Pardo's work include Bacterial Identification and Susceptibility Testing (3 papers), Streptococcal Infections and Treatments (2 papers) and Urinary Tract Infections Management (1 paper). Joe Pardo is often cited by papers focused on Bacterial Identification and Susceptibility Testing (3 papers), Streptococcal Infections and Treatments (2 papers) and Urinary Tract Infections Management (1 paper). Joe Pardo collaborates with scholars based in United States. Joe Pardo's co-authors include Asmita Gupte, Ashutosh M. Shukla, Kenneth H. Rand, Kenneth Klinker, Jonathan C. Cho, José Montero, Nicholas W. Carris, Reuben Ramphal, John A. Armitstead and Nicole M. Iovine and has published in prestigious journals such as Journal of Clinical Microbiology, Annals of Pharmacotherapy and American Journal of Health-System Pharmacy.

In The Last Decade

Joe Pardo

7 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joe Pardo United States 6 152 119 108 78 56 7 336
Clare Fogarty Canada 8 257 1.7× 80 0.7× 114 1.1× 105 1.3× 27 0.5× 11 368
Masayuki Nigo United States 15 158 1.0× 67 0.6× 167 1.5× 39 0.5× 76 1.4× 40 494
Eliahu Bishburg United States 12 259 1.7× 46 0.4× 119 1.1× 68 0.9× 31 0.6× 37 432
Chien-Hao Tseng Taiwan 9 128 0.8× 38 0.3× 57 0.5× 40 0.5× 13 0.2× 29 309
Timothy R. Pasquale United States 10 125 0.8× 57 0.5× 80 0.7× 31 0.4× 34 0.6× 16 282
Mohammad Bosaeed Saudi Arabia 11 163 1.1× 27 0.2× 158 1.5× 22 0.3× 59 1.1× 52 373
Kyle C. Molina United States 13 348 2.3× 74 0.6× 163 1.5× 42 0.5× 38 0.7× 41 477
Hamad Abdel Hadi Qatar 11 163 1.1× 51 0.4× 97 0.9× 26 0.3× 200 3.6× 47 487
Vanesa Antón-Vázquez United Kingdom 10 47 0.3× 78 0.7× 99 0.9× 49 0.6× 134 2.4× 29 297
David Mushatt United States 13 298 2.0× 27 0.2× 260 2.4× 117 1.5× 13 0.2× 30 559

Countries citing papers authored by Joe Pardo

Since Specialization
Citations

This map shows the geographic impact of Joe Pardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joe Pardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joe Pardo more than expected).

Fields of papers citing papers by Joe Pardo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joe Pardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joe Pardo. The network helps show where Joe Pardo may publish in the future.

Co-authorship network of co-authors of Joe Pardo

This figure shows the co-authorship network connecting the top 25 collaborators of Joe Pardo. A scholar is included among the top collaborators of Joe Pardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joe Pardo. Joe Pardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Pardo, Joe, et al.. (2020). The journey of remdesivir: from Ebola to COVID-19. Drugs in Context. 9. 1–9. 114 indexed citations
2.
Cho, Jonathan C., et al.. (2018). Meropenem/Vaborbactam, the First Carbapenem/β-Lactamase Inhibitor Combination. Annals of Pharmacotherapy. 52(8). 769–779. 41 indexed citations
3.
Pardo, Joe, et al.. (2015). Clinical and economic impact of antimicrobial stewardship interventions with the FilmArray blood culture identification panel. Diagnostic Microbiology and Infectious Disease. 84(2). 159–164. 98 indexed citations
4.
Carris, Nicholas W., et al.. (2015). Minocycline as A Substitute for Doxycycline in Targeted Scenarios: A Systematic Review. Open Forum Infectious Diseases. 2(4). ofv178–ofv178. 31 indexed citations
5.
Pardo, Joe & John A. Armitstead. (2014). New practitioner engagement in continuous professional development. American Journal of Health-System Pharmacy. 71(10). 788–789. 3 indexed citations
6.
Pardo, Joe, et al.. (2014). Detection of Neisseria meningitidis from Negative Blood Cultures and Cerebrospinal Fluid with the FilmArray Blood Culture Identification Panel. Journal of Clinical Microbiology. 52(6). 2262–2264. 8 indexed citations
7.
Pardo, Joe, et al.. (2013). Time to Positivity of Blood Cultures Supports Antibiotic De-escalation at 48 Hours. Annals of Pharmacotherapy. 48(1). 33–40. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026